"进入老龄化社会，阿尔茨海默病（大家常说的老年痴呆）越来越受大众关注。阿尔茨海默病一旦进入 中重度就难以逆转，因此早筛查、早干预是非常重要。"宁玉萍向羊城晚报记者介绍，"5G脑心动车就 是希望打破空间限制，把移动式脑健康智慧服务，送到有需要的人身边。" 羊城晚报记者 林清清 通讯员 张舒维 傅文臻 林冬霓 一辆车、一顶帽、一管血……上车半小时，就能快速检测是否老年痴呆，还能在车上进行各种人机互动 训练！ 在广东，一辆融合搭载了10多项专利技术成果的全球首辆5G脑心动车，自去年8月落地就备受瞩目，11 月开进全运会会场，12月又开赴揭阳、普宁。据记者了解，今年它将开到福建龙岩、西藏林芝、云南大 理等地，并不断升级技术，从粤港澳大湾区核心区向外稳步辐射，提供脑健康智慧服务的输出标准样 本，打造可复制的"广东方案"。近日，记者采访该医工结合的研发团队，解密"广东智造"背后的"科技 向善"力量。 一辆车：搭载10余项专利技术成果 "我要把结果带回去给家人看看，让他们也重视脑健康！"在广州白云山上，爱运动的60多岁王大姐，登 上5G脑心动车，只花了15分钟就完成了测试。 脑机接口15分钟快测、最快3分钟可出报告、一管血 ...

Core Viewpoint - Shenzhen Yingjixin Technology Co., Ltd. (referred to as Yingjixin) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws, following misleading statements made on the Shanghai Stock Exchange's E-interaction platform [1][2][4]. Group 1: Investigation Details - On February 13, 2026, Yingjixin received a notice from the CSRC regarding the initiation of an investigation due to suspected violations of information disclosure laws [1][3]. - The CSRC's investigation stems from a January 6, 2026, incident where Yingjixin engaged in a "self-questioning and answering" format on the E-interaction platform, which was deemed to have misled investors [2][4]. - The CSRC has stated that it will conduct a comprehensive investigation and take legal action to maintain market health [2][4]. Group 2: Product and Market Impact - Yingjixin claimed to have entered the brain-computer interface chip sector with its IPA1299 chip, which is an 8-channel, low-noise 24-bit ADC chip designed for high-precision measurement of human bioelectrical signals [5]. - The IPA1299 chip has been mass-produced and is said to have performance parameters comparable to leading overseas chip products; however, the company later clarified that the chip was developed in collaboration with a subsidiary and is still in the market cultivation phase, with no significant sales impact on the company's performance [5][6]. - The company reported a total revenue of 1.612 billion yuan for the fiscal year 2025, representing a year-on-year increase of 12.65%, and a net profit of 177 million yuan, up 42.81% year-on-year [6]. Group 3: Investor Implications - Investors who purchased Yingjixin shares between January 6, 2026, and February 13, 2026, and sold or held them after February 14, 2026, may be eligible for compensation due to the ongoing investigation [6].

Core Viewpoint - The 2026 Future Industries New Materials Expo (FINE 2026) aims to lead global innovation in new materials, emphasizing their critical role in the transformation of high-tech industries and future economic development [1][2]. Group 1: Event Overview - FINE 2026 will take place from June 10 to June 12, 2026, at the Shanghai New International Expo Center, featuring a total exhibition area of 50,000 square meters and over 300 strategic and cutting-edge technology reports [2][18]. - The expo will focus on popular innovations applicable to various industries, including artificial intelligence, aerospace, smart vehicles, and renewable energy, while addressing five common needs in future industries: advanced semiconductors, advanced batteries, lightweight functionalization, low-carbon sustainability, and thermal management [2][10]. Group 2: Historical Context and Participation - The previous events, including the 2025 International Carbon Materials Expo and the 2025 Thermal Management Expo, achieved record attendance with over 35,000 professional visitors from 27 countries and regions, showcasing more than 500 exhibitors [7][36]. - The expected participation for FINE 2026 is over 100,000 professional visitors, with targeted invitations to over 5,000 industry investors to facilitate connections between startups and industry resources [35][37]. Group 3: Thematic Focus and Special Features - FINE 2026 will feature seven specialized thematic exhibition areas, including advanced semiconductors, AI chips, thermal management, and sustainable materials, aiming to present a comprehensive chain of innovation from components to cutting-edge technologies [13][15]. - The event will host over 30 forums with more than 300 renowned experts discussing trends in technology, investment strategies, and advanced manufacturing techniques related to new materials [22][24]. Group 4: Strategic Importance - The expo is positioned as a critical platform for technology transfer and industry innovation, leveraging China's growing influence in sectors like new energy vehicles, photovoltaics, and robotics, which are expected to create significant market opportunities for new materials [10][36]. - The timing of the event in June is seen as a strategic opportunity to capture business prospects for the second half of the year, supported by Shanghai's robust industrial and technological ecosystem [10][36].

Core Viewpoint - The 2026 Spring Festival gathering held by the Central Committee of the Communist Party of China and the State Council emphasizes the importance of unity and the celebration of achievements amidst challenges faced in the past year [1][11]. Group 1: Event Overview - The Spring Festival gathering took place on February 14, 2026, with key leaders including Xi Jinping, who delivered a speech to extend New Year greetings to various groups including citizens from Hong Kong, Macau, Taiwan, and overseas [1][16]. - The gathering featured a traditional setting with attendees seated around round tables, with only a cup of tea present, reflecting a long-standing practice aimed at promoting integrity [3][18]. Group 2: Economic Performance and Policies - Xi Jinping highlighted the resilience and vitality of the Chinese economy, stating that it has shown strong performance despite facing complex international and domestic challenges [11][12]. - The economic total surpassed 140 trillion yuan, marking significant milestones in economic growth during the "14th Five-Year Plan" period [12][26]. - In 2025, China's R&D expenditure intensity reached 2.8%, exceeding the OECD average for the first time, indicating a focus on innovation and quality [13][27]. Group 3: Governance and Values - The concept of "correct performance view" was reiterated, emphasizing the importance of aligning governance with the needs of the people and ensuring that achievements withstand the test of practice, history, and public scrutiny [14][28]. - Xi Jinping stressed that the Party exists for the people, and all work should aim for the happiness of the populace, reinforcing the principle of "people first" [15][28].

Core Insights - The signing of Hui Chuang Medical as the first clinical transformation partner at the Jiangsu Brain-Computer Interface Research Institute marks a significant step in filling the gap in the optical brain-computer interface industrialization process in China [1][2] - Brain-computer interfaces are recognized as a disruptive technology that integrates life sciences, information technology, and artificial intelligence, and are a key focus in the 14th Five-Year Plan [1] - The Jiangsu Brain-Computer Interface Research Institute aims to overcome challenges in technology, clinical transformation, and industry cultivation, positioning itself as a national-level innovation and service platform [3] Company Insights - Hui Chuang Medical is the first national-level "specialized and innovative" small giant enterprise in the optical brain-computer interface field, with its core technology likened to an "optical CT" for the brain, allowing non-invasive detection of brain activity [1] - The company has established a strong market presence, with products already in over 1,000 high-end medical and research institutions across China [1] - The chairman of Hui Chuang Medical has been appointed as the vice president of the research institute, indicating a shift from being a service provider to a leader in industry development [2] Industry Insights - The brain-computer interface industry is still in its early stages, facing challenges such as a long industrial chain, high technical barriers, scattered enterprise distribution, and significant investment risks [3] - The Jiangsu Brain-Computer Interface Innovation Industrial Park has attracted 11 companies, covering key areas such as optical devices, flexible optoelectronic materials, multimodal fusion algorithms, and rehabilitation industry upgrades [3] - Jiangsu's unique advantages stem from its complete industrial chain foundation and deep industry accumulation, facilitating a systematic integration of technology, clinical applications, manufacturing, and capital [3]

证监会对深圳英集芯科技股份有限公司(以下简称"英集芯")相关信息披露涉嫌误导性陈述立案调查。 据证监会官网2月13日消息，2026年1月6日，英集芯在上证E互动平台人为策划"自问自答"，信息披露构成误导性陈述。近日，证监会已对英集芯立案调 查。下一步，将在全面调查的基础上依法处理，切实维护市场健康发展。 2月13日晚间，英集芯公告称，公司于2月13日收到中国证监会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据《中华人民共和国证券法》 《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司进行立案。 "自问自答"蹭热点 根据上证E互动平台，1月6日，有投资者就"脑机接口"相关问题向英集芯提问。英集芯回复时提到，公司已涉足脑机接口芯片领域，推出的IPA1299芯片 专用于人体生物电信号的高精度测量，可适用于脑电信号采集等脑机接口相关场景，已量产出货，性能参数可媲美海外头部芯片产品。 1月6日晚间，英集芯收到上海证券交易所(以下简称"上交所")下发的监管工作函，处理事由为"关于深圳英集芯科技股份有限公司E互动回复内容的监管工 作函"。 经监管督促，英集芯1月7日早间披露《关于上证E互动平台有关问题回复 ...

中经记者 孙汝祥 夏欣 北京报道 2026年2月13日，证监会披露，对英集芯（688209.SH）立案调查。案由为英集芯在上证E互动平台人为 策划"自问自答"，信息披露构成误导性陈述。 值得注意的是，这已是2026年1月14日以来，证监会官网通报的第4家因涉嫌误导性陈述而被立案调查的 上市公司。 此前被立案调查的公司分别为向日葵（300111.SZ）、容百科技（688005.SH）、亚辉龙 （688575.SH）。其中容百科技已收到《行政处罚事先告知书》，宁波证监局拟对公司及两名责任人合 计罚款950万元。 业内专家对《中国经营报》记者表示，当前上市公司"蹭热点"、误导中小投资者的现象有愈演愈烈趋 势，监管部门以"高频立案+快速严厉处罚"形成震慑，有利于倒逼上市公司信披审慎、风险充分提示。 英集芯"自问自答"蹭"脑机接口"热点 2月13日，证监会官网通报，英集芯于2026年1月6日在上证E互动平台人为策划"自问自答"，信息披露构 成误导性陈述。该会已对英集芯立案调查。下一步，将在全面调查的基础上依法处理，切实维护市场健 康发展。 在证监会立案之前，上交所已于1月7日对英集芯及时任董事会秘书吴任超予以监管警示。 ...

连日来，A股上市企业"蹭热点"式信披遭处罚屡见不鲜，但被证监会直指"自问自答"实属罕见。 2月13日晚间，中国证监会官网发布消息称，2026年1月6日，英集芯在上证E互动平台人为策划"自问自答"，其信息披露构成误导性陈述。 近日，证监会已对英集芯立案调查。证监会表示，下一步将在全面调查的基础上依法处理，切实维护市场健康发展。 此前，正值脑机接口概念在A股市场持续升温之际，英集芯于1月6日在上证E互动平台回应一则"投资者提问"时称，"公司通过早期投资布 局，已涉足脑机接口芯片领域。公司推出的IPA1299是一款8通道、低噪声24位ADC芯片，专用于人体生物电信号的高精度测量，可适用于 脑电信号采集等脑机接口相关场景。IPA1299芯片已量产出货，性能参数可媲美海外头部芯片产品"。 当晚，上交所火速下发监管工作函，要求公司作出情况说明。英集芯承认，公司的IPA1299芯片产品为与参股公司精芯唯尔（常州）电子 科技有限公司共同推出，该产品尚处市场培育期，尚未实现规模化销售，暂未对公司业绩产生重大影响，未来销售情况存在不确定性，其 应用于非侵入式脑机接口领域，与当前国际上的侵入式脑机接口存在显著技术路径差异。 尽管公 ...

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has announced an investigation into Yingjixin for misleading statements made during a Q&A session on the Shanghai Stock Exchange's E-interaction platform, emphasizing the need to maintain healthy market development [1]. Group 1: Company Developments - On January 6, 2026, Yingjixin responded to an investor inquiry regarding its involvement in the brain-computer interface (BCI) market, stating that it has entered this field through early investments and has launched the IPA1299 chip, which is designed for high-precision measurement of biological electrical signals [3]. - The IPA1299 chip is an 8-channel, low-noise 24-bit ADC chip that has already been mass-produced and is comparable in performance to leading overseas chip products [3]. - Yingjixin expressed confidence in the broad application prospects of brain-computer interfaces and plans to continue investing resources to achieve breakthroughs in related technologies [3]. Group 2: Market and Regulatory Response - On January 7, Yingjixin provided further clarification, noting that the IPA1299 product is still in the market cultivation phase for non-invasive brain-computer interfaces and has not yet achieved significant sales, which has not materially impacted the company's performance [4]. - Despite acknowledging the uncertainties surrounding this business, Yingjixin's stock rose by 4.51% on January 7 [5]. - The Shanghai Stock Exchange promptly issued a regulatory warning to Yingjixin and its then-secretary of the board, Wu Renchao, following the misleading statements [5]. Group 3: Company Background - Yingjixin was established in 2014 and went public on the Sci-Tech Innovation Board in 2022. Its main business includes power management chips, fast charging protocol chips, data transmission processing chips, wireless signal processing chips, and smart audio-video chips, with applications across various consumer electronics and automotive electronics [5].

2月13日晚，证监会在官网发布公告称，对英集芯相关信息披露涉嫌误导性陈述立案调查。 据悉，2026年1月6日，深圳英集芯科技股份有限公司在上证E互动平台人为策划"自问自答"，信息披露构成误导性陈述。近日，证监会已对英集芯立案调 查。下一步，将在全面调查的基础上依法处理，切实维护市场健康发展。 同日晚，英集芯亦公告称，收到证监会下发的《立案告知书》。因涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》 等法律法规，中国证监会决定对其进行立案。 英集芯同时以公司身份回复称，"公司通过早期投资布局，已涉足脑机接口芯片领域。公司推出的IPA1299是一款8通道、低噪声24位ADC芯片，专用于人体 生物电信号的高精度测量，可适用于脑电信号采集等脑机接口相关场景。IPA1299芯片已量产出货，性能参数可媲美海外头部芯片产品。公司对脑机接口的 广泛应用前景充满信心，将持续投入资源，不断深耕脑机接口相关技术，力争取得更多突破性进展，为客户带来更多优质产品。" 1月7日晚，上交所对英集芯及有关责任人予以监管警示的决定。上交所指出，当前市场对"脑机接口"相关概念高度关注，公司发布相关信息尤其应当注意审 ...